Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001181431-12-049246

Chief Executive Officer acquired 2,025,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FREER RICHARD J Chief Executive Officer 2012-08-22 Other acquisition +2,025,000 $0.02 $40,500 4,638,426 D: show line 1 in the form
Loading xslF345X03/rrd355310.xml…